Exclusive Summary

• Backed by US-FDA GMP certification and US ANDA registration, providing top-tier quality endorsement to enable fast-track regulatory approvals globally.
• Covers three massive indications (T2DM, Heart Failure, CKD) addressing a global patient pool exceeding 1 billion, guaranteeing explosive and sustained market demand.
• Flawless timing to capitalize on the global patent cliff; combined with highly cost-effective Chinese manufacturing, it is an ideal asset for winning national tenders and rapid market penetration.